Nevro plans to raise more than $100 million in an initial public offering of stock for its implantable spinal cord stimulation system to treat chronic pain.
Nevro Corp. said it plans to raise more than $100 million in an initial public offering of stock for its implantable spinal cord stimulation system to treat chronic pain.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1EkE2Mm
Cap comentari:
Publica un comentari a l'entrada